489 related articles for article (PubMed ID: 20435321)
21. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
[TBL] [Abstract][Full Text] [Related]
22. Diastolic Pulmonary Gradient as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implantation.
Alnsasra H; Asleh R; Schettle SD; Pereira NL; Frantz RP; Edwards BS; Clavell AL; Maltais S; Daly RC; Stulak JM; Rosenbaum AN; Behfar A; Kushwaha SS
J Am Heart Assoc; 2019 Aug; 8(16):e012073. PubMed ID: 31411097
[TBL] [Abstract][Full Text] [Related]
23. Left Ventricular Assist Devices or Inotropes for Decreasing Pulmonary Vascular Resistance in Patients with Pulmonary Hypertension Listed for Heart Transplantation.
Al-Kindi SG; Farhoud M; Zacharias M; Ginwalla MB; ElAmm CA; Benatti RD; Oliveira GH
J Card Fail; 2017 Mar; 23(3):209-215. PubMed ID: 27374840
[TBL] [Abstract][Full Text] [Related]
24. A Decade of Experience With Continuous-Flow Left Ventricular Assist Devices.
John R; Holley CT; Eckman P; Roy SS; Cogswell R; Harvey L; Shumway S; Liao K
Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):363-375. PubMed ID: 28043445
[TBL] [Abstract][Full Text] [Related]
25. Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device-associated aortic insufficiency and improves cardiac hemodynamics.
Parikh KS; Mehrotra AK; Russo MJ; Lang RM; Anderson A; Jeevanandam V; Freed BH; Paul JD; Karol J; Nathan S; Shah AP
JACC Cardiovasc Interv; 2013 Jan; 6(1):84-9. PubMed ID: 23347865
[TBL] [Abstract][Full Text] [Related]
26. Decoupling Between Diastolic Pulmonary Artery and Pulmonary Capillary Wedge Pressures Is Associated With Right Ventricular Dysfunction and Hemocompatibility-Related Adverse Events in Patients With Left Ventricular Assist Devices.
Imamura T; Narang N; Kim G; Raikhelkar J; Chung B; Nguyen A; Holzhauser L; Rodgers D; Kalantari S; Smith B; Ota T; Song T; Juricek C; Burkhoff D; Jeevanandam V; Sayer G; Uriel N
J Am Heart Assoc; 2020 Apr; 9(7):e014801. PubMed ID: 32223394
[TBL] [Abstract][Full Text] [Related]
27. Effects of the HeartMate II continuous-flow left ventricular assist device on right ventricular function.
Lee S; Kamdar F; Madlon-Kay R; Boyle A; Colvin-Adams M; Pritzker M; John R
J Heart Lung Transplant; 2010 Feb; 29(2):209-15. PubMed ID: 20113911
[TBL] [Abstract][Full Text] [Related]
28. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
29. Mitral valve repair for severe mitral valve regurgitation during left ventricular assist device implantation.
Pawale A; Itagaki S; Parikh A; Pinney SP; Adams DH; Anyanwu AC
J Thorac Cardiovasc Surg; 2019 May; 157(5):1841-1848.e1. PubMed ID: 31288361
[TBL] [Abstract][Full Text] [Related]
30. Normalisation of haemodynamics in patients with end-stage heart failure with continuous-flow left ventricular assist device therapy.
Gupta S; Woldendorp K; Muthiah K; Robson D; Prichard R; Macdonald PS; Keogh AM; Kotlyar E; Jabbour A; Dhital K; Granger E; Spratt P; Jansz P; Hayward CS
Heart Lung Circ; 2014 Oct; 23(10):963-9. PubMed ID: 24973864
[TBL] [Abstract][Full Text] [Related]
31. Use of continuous flow ventricular assist devices in patients with heart failure and a normal ejection fraction: a computer-simulation study.
Moscato F; Wirrmann C; Granegger M; Eskandary F; Zimpfer D; Schima H
J Thorac Cardiovasc Surg; 2013 May; 145(5):1352-8. PubMed ID: 22841169
[TBL] [Abstract][Full Text] [Related]
32. Right ventricular function and residual mitral regurgitation after left ventricular assist device implantation determines the incidence of right heart failure.
Tang PC; Haft JW; Romano MA; Bitar A; Hasan R; Palardy M; Wu X; Aaronson KD; Pagani FD
J Thorac Cardiovasc Surg; 2020 Mar; 159(3):897-905.e4. PubMed ID: 31101350
[TBL] [Abstract][Full Text] [Related]
33. Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation-a preliminary study.
Martin J; Siegenthaler MP; Friesewinkel O; Fader T; van de Loo A; Trummer G; Berchtold-Herz M; Beyersdorf F
Eur J Cardiothorac Surg; 2004 Jun; 25(6):971-7. PubMed ID: 15144997
[TBL] [Abstract][Full Text] [Related]
34. Surgical correction of aortic valve insufficiency after left ventricular assist device implantation.
Atkins BZ; Hashmi ZA; Ganapathi AM; Harrison JK; Hughes GC; Rogers JG; Milano CA
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1247-52. PubMed ID: 23870154
[TBL] [Abstract][Full Text] [Related]
35. [Changes in Pulmonary Hemodynamics Resulted From Long-Term Mechanical Heart Support].
Doronin DV; Fomichev AV; Agaeva KA; Zhul'kov MO; Khvan DS; Sirota DA; Chernyavskii AM
Kardiologiia; 2023 May; 63(4):16-21. PubMed ID: 37165990
[TBL] [Abstract][Full Text] [Related]
36. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?
Klotz S; Stypmann J; Welp H; Schmid C; Drees G; Rukosujew A; Scheld HH
Ann Thorac Surg; 2006 Nov; 82(5):1774-8. PubMed ID: 17062246
[TBL] [Abstract][Full Text] [Related]
37. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
[TBL] [Abstract][Full Text] [Related]
38. Left Ventricular Assist Devices in Pulmonary Hypertension Group 2 With Significantly Elevated Pulmonary Vascular Resistance: A Bridge to Cure.
Selim AM; Wadhwani L; Burdorf A; Raichlin E; Lowes B; Zolty R
Heart Lung Circ; 2019 Jun; 28(6):946-952. PubMed ID: 29895486
[TBL] [Abstract][Full Text] [Related]
39. Left ventricular reverse remodeling with a continuous flow left ventricular assist device measured by left ventricular end-diastolic dimensions and severity of mitral regurgitation.
Morgan JA; Brewer RJ; Nemeh HW; Murthy R; Williams CT; Lanfear DE; Tita C; Paone G
ASAIO J; 2012; 58(6):574-7. PubMed ID: 23103696
[TBL] [Abstract][Full Text] [Related]
40. Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical Trial.
Fukushima N; Tatsumi E; Seguchi O; Takewa Y; Hamasaki T; Onda K; Yamamoto H; Hayashi T; Fujita T; Kobayashi J
Cardiovasc Drugs Ther; 2018 Aug; 32(4):373-379. PubMed ID: 29948739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
